Agios Pharmaceuticals AGIO Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $20.75M+138% | $19.97M+86.1% | $12.88M+43.7% | $12.46M+44.6% | $8.73M+6.6% | ||
| $1.32M+21.6% | $1.88M+49.1% | $1.68M+114% | $1.7M+13.8% | $1.09M+73.0% | ||
| $19.43M+154% | $18.09M+91.0% | $11.2M+36.9% | $10.75M+51.0% | $7.64M+1.0% | ||
| 93.6%+6.1pp | 90.6%+2.3pp | 87%-4.3pp | 86.3%+3.7pp | 87.6%-4.8pp | ||
| $81.15M+11.6% | $88.06M+6.3% | $86.8M+19.8% | $91.94M+18.8% | $72.74M+6.0% | ||
| $48.3M+16.3% | $51.61M-0.2% | $41.27M+7.1% | $45.87M+29.1% | $41.53M+33.9% | ||
| $130.77M+13.4% | $141.55M+4.3% | $129.75M+16.1% | $139.51M+21.9% | $115.36M+15.1% | ||
| -$110.03M-3.2% | -$121.58M+2.8% | -$116.87M-13.7% | -$127.06M-20.1% | -$106.63M-15.8% | ||
| -530.3%+692pp | -608.9%+556pp | -907.4%+240pp | -1,020.1%+208pp | -1,222%-97.6pp | ||
| $10.8M-32.9% | $12.41M-31.1% | $13.37M+2.4% | $14.51M+78.7% | $16.09M+81.0% | ||
| $119K-90.5% | $113K-93.0% | $67K-95.9% | $523K-66.9% | $1.25M-23.3% | ||
| -$99.11M-11.0% | -$108.04M— | -$103.43M-111% | -$112.02M-16.5% | -$89.29M-9.5% | ||
| -477.7%+546pp | -541.1%— | -803.1%-11,378pp | -899.4%+216pp | -1,023.3%-27.4pp | ||
| -$1.69-9.0% | -$1.85— | -$1.78-111% | -$1.93-14.2% | -$1.55-6.9% | ||
| -$1.69-9.0% | -$1.85— | -$1.78-111% | -$1.93-14.2% | -$1.55-6.9% | ||
| 58.8M+2.3% | 58M+0.1% | 58.1M-0.5% | 57.9M+2.0% | 57.5M+1.9% | ||
| 58.8M+2.3% | 58M+2.1% | 58.1M+2.1% | 57.9M+2.0% | 57.5M+1.9% | ||
| $10.8M-32.9% | $12.41M-31.1% | $13.37M+2.4% | $14.51M+78.7% | $16.09M+81.0% | ||
| $119K-90.5% | $113K-93.0% | $67K-95.9% | $523K-66.9% | $1.25M-23.3% | ||
| $20.75M+138% | $19.97M+86.1% | $12.88M+43.7% | $12.46M+44.6% | $8.73M+6.6% | ||
| -$110.03M-3.2% | -$121.58M+2.8% | -$116.87M-13.7% | -$127.06M-20.1% | -$106.63M-15.8% | ||
| -$108.66M-3.1% | -$120.31M+2.7% | -$115.5M-13.8% | -$125.8M-20.7% | -$105.35M-16.1% | ||
| -$108.66M-3.1% | -$120.31M+2.7% | -$115.5M-13.8% | -$125.8M-20.7% | -$105.35M-16.1% | ||
| -523.8%+684pp | -602.6%+550pp | -896.7%+235pp | -1,010%+200pp | -1,207.3%-99.4pp | ||
| -$110.03M-3.2% | -$121.58M+2.8% | -$116.87M-13.7% | -$127.06M-20.1% | -$106.63M-15.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Agios Pharmaceuticals's profit margins?
- Gross margin is 90.0% and operating margin is -720.0%, with a -639.8% net margin.
- Where does Agios Pharmaceuticals's income statement data come from?
- Every line is extracted from Agios Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.